Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients

BACKGROUND: Although programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) checkpoint inhibitors have shown prominent efficacy for treatment of advanced lung cancer, the outcomes of metastatic lung cancer remain poor throughout the world. Although progression-free survival (PFS) a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Wang, Yida, Chen, Hanxiao, Zhang, Tianzhuo, Yang, Xue, Zhong, Jia, Wang, Yuyan, Chi, Yujia, Wu, Meina, An, Tongtong, Li, Jianjie, Zhao, Xinghui, Dong, Zhi, Wang, Ziping, Zhao, Jun, Zhuo, Minglei, Huang, Jing
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859784/
https://ncbi.nlm.nih.gov/pubmed/33553326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1513
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы